Search all trials

Find therapies in clinical trials near you – page 80

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Investigational

Study on Radiotherapy with Xevinapant or Placebo for Older Patients with Advanced Head and Neck Cancer

Investigational

Germany

Participants:65+ years
Substances:Xevinapant

Contact Research Centre

Type 2 diabetes mellitus+3

Not recruiting

Registered drugNo placebo

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Canagliflozin

Contact Research Centre

Colitis ulcerative

Not recruiting

Registered drug

Study on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis

Registered drug

Germany

Participants:0–17 years
Substances:Ustekinumab

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel

Contact Research Centre

Hepatic encephalopathy

Not recruiting

Investigational

Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Rifaximin

Contact Research Centre

Crohn's disease

Not recruiting

Registered drug

Study on Ustekinumab for Children with Moderate to Severe Crohn's Disease

Registered drug

Germany

Participants:0–17 years
Substances:Ustekinumab

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Gastrointestinal stromal tumour

Not recruiting

Registered drugNo placebo

Study of Ripretinib vs Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumor with Specific KIT Exon Mutations Previously Treated with Imatinib

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ripretinib

Contact Research Centre

Magnetic resonance imaging+1

Not recruiting

Registered drugNo placebo

Study Comparing Gadoquatrane with Gadoteric Acid, Gadoteridol, and Gadobutrol for MRI in Patients with Non-CNS Conditions

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Gadobutrol

Contact Research Centre

Diffuse large B-cell lymphoma refractory+1

Not recruiting

Registered drugNo placebo

Study on ALLO-647 and ALLO-501A for Adults with Relapsed or Refractory Large B-Cell Lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Allo-501A

Contact Research Centre

Squamous cell carcinoma of head and neck+1

Not recruiting

Registered drugNo placebo

Study of IO102-IO103 and Pembrolizumab for Patients with Resectable Melanoma and Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Io103 Acetate

Contact Research Centre

Find therapies in clinical trials near you – page 80

987 trials match your criteria

Malignant melanoma

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Squamous cell carcinoma of head and neck

Study on Radiotherapy with Xevinapant or Placebo for Older Patients with Advanced Head and Neck Cancer

Type 2 diabetes mellitus+3

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Colitis ulcerative

Study on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis

Endometrial cancer

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Hepatic encephalopathy

Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

Crohn's disease

Study on Ustekinumab for Children with Moderate to Severe Crohn's Disease

Triple negative breast cancer

Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Gastrointestinal stromal tumour

Study of Ripretinib vs Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumor with Specific KIT Exon Mutations Previously Treated with Imatinib

Magnetic resonance imaging+1

Study Comparing Gadoquatrane with Gadoteric Acid, Gadoteridol, and Gadobutrol for MRI in Patients with Non-CNS Conditions

Diffuse large B-cell lymphoma refractory+1

Study on ALLO-647 and ALLO-501A for Adults with Relapsed or Refractory Large B-Cell Lymphoma

Squamous cell carcinoma of head and neck+1

Study of IO102-IO103 and Pembrolizumab for Patients with Resectable Melanoma and Head and Neck Squamous Cell Carcinoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.